{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:57:04Z","timestamp":1791212224077,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2002,11,1]],"date-time":"2002-11-01T00:00:00Z","timestamp":1036108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,11,1]],"date-time":"2002-11-01T00:00:00Z","timestamp":1036108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2002,11]]},"DOI":"10.1136\/ard.61.suppl_2.ii84","type":"journal-article","created":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T19:21:06Z","timestamp":1414005666000},"page":"ii84-ii86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":268,"special_numbering":"S2","title":["Bone destruction in arthritis"],"prefix":"10.1016","volume":"61","author":[{"given":"E M","family":"Gravallese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.61.suppl_2.ii84_bib1","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/art.1780270902","article-title":"Chondroclasts and osteoclasts at subchondral sites of erosion in the rheumatoid joint","volume":"27","author":"Bromley","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib2","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P","article-title":"Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor","volume":"43","author":"Gravallese","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib3","first-page":"1887","article-title":"Cysteine proteinase cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction","volume":"25","author":"Hummel","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib4","first-page":"943","article-title":"Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis","volume":"152","author":"Gravallese","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib5","first-page":"1154","article-title":"Osteoclast-like cells in murine collagen induced arthritis","volume":"25","author":"Suzuki","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib6","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/1529-0131(200004)43:4<821::AID-ANR12>3.0.CO;2-T","article-title":"Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis","volume":"43","author":"Romas","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib7","first-page":"17","article-title":"The erosive front: a topographic study of the junction between the pannus and the subchondral plate in the macerated rheumatoid metacarpal head","volume":"15","author":"Leisen","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib8","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL","volume":"95","author":"Yasuda","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib10","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1084\/jem.186.12.2075","article-title":"TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor","volume":"186","author":"Wong","year":"1997","journal-title":"J Exp Med"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/36593","article-title":"A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function","volume":"390","author":"Anderson","year":"1997","journal-title":"Nature"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib12","doi-asserted-by":"crossref","first-page":"25190","DOI":"10.1074\/jbc.272.40.25190","article-title":"TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells","volume":"272","author":"Wong","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib13","first-page":"2293","article-title":"The American Society for Bone and Mineral Research President\u2019s Committee on Nomenclature","volume":"15","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib14","first-page":"761","article-title":"The American Society for Bone and Mineral Research President\u2019s Committee on Nomenclature","volume":"27","year":"2000","journal-title":"Bone"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib15","doi-asserted-by":"crossref","first-page":"13613","DOI":"10.1074\/jbc.274.19.13613","article-title":"Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)- converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival","volume":"274","author":"Lum","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","article-title":"OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis","volume":"397","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1567-5769(01)00134-5","article-title":"Human osteosarcoma-derived cell lines produce soluble factor(s) that induces differentiation of blood monocytes to osteoclast-like cells","volume":"2","author":"Miyamoto","year":"2002","journal-title":"Int Immunopharmacol"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib18","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1172\/JCI13890","article-title":"Crystal structure of the TRANCE\/RANKL cytokine reveals determinants of receptor-ligand specificity","volume":"108","author":"Lam","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib19","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1006\/bbrc.2000.2314","article-title":"Cancer cells responsible for humoral hypercalcemia express mRNA encoding a secreted form of ODF\/TRANCE that induces osteoclast formation","volume":"269","author":"Nagai","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib20","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1073\/pnas.96.7.3540","article-title":"Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand","volume":"96","author":"Hsu","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib21","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S8756-3282(99)00210-0","article-title":"Osteoblasts\/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor\/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappaB ligand","volume":"25","author":"Udagawa","year":"1999","journal-title":"Bone"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/(SICI)1097-4644(19990201)72:2<251::AID-JCB9>3.0.CO;2-W","article-title":"Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors","volume":"72","author":"Shalhoub","year":"1999","journal-title":"J Cell Biochem"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib23","doi-asserted-by":"crossref","first-page":"434","DOI":"10.4049\/jimmunol.163.1.434","article-title":"Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function","volume":"163","author":"Jimi","year":"1999","journal-title":"J Immunol"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib24","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1083\/jcb.145.3.527","article-title":"The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts","volume":"145","author":"Burgess","year":"1999","journal-title":"J Cell Biol"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib25","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0002-9440(10)64556-7","article-title":"Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo","volume":"157","author":"Lacey","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib26","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib27","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1359\/jbmr.2001.16.6.1015","article-title":"The ratio of messenger RNA levels of receptor activator of nuclear factor kappaB ligand to osteoprotegerin correlates with bone remodeling indices in normal human cancellous bone but not in osteoarthritis","volume":"16","author":"Fazzalari","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib28","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1084\/jem.192.4.463","article-title":"Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis","volume":"192","author":"Min","year":"2000","journal-title":"J Exp Med"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib29","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1210\/endo.141.12.7840","article-title":"The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated","volume":"141","author":"Gori","year":"2000","journal-title":"Endocrinology"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib30","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W","article-title":"Involvement of receptor activator of nuclear factor kappa-B ligand\/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis","volume":"43","author":"Takayanagi","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib31","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/46303","article-title":"Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand","volume":"402","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib32","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1006\/bbrc.1999.1623","article-title":"Activated T lymphocytes support osteoclast formation in vitro","volume":"265","author":"Horwood","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib33","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1002\/1529-0131(200011)43:11<2523::AID-ANR20>3.0.CO;2-Z","article-title":"Expression of osteoclast differentiation factor in rheumatoid arthritis","volume":"43","author":"Shigeyama","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib34","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/1529-0131(200105)44:5<1003::AID-ANR179>3.0.CO;2-#","article-title":"Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients","volume":"44","author":"Kotake","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib35","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH672>3.0.CO;2-W","article-title":"Rheumatoid arthritis synovial macrophage-osteoclast differentiation is osteoprotegerin ligand-dependent","volume":"192","author":"Itonaga","year":"2000","journal-title":"J Pathol"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib36","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/rheumatology\/40.6.623","article-title":"Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint","volume":"40","author":"Haynes","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib37","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/rheumatology\/40.6.673","article-title":"Osteoclast-like cells in an in vitro model of bone destruction by rheumatoid synovium","volume":"40","author":"Suzuki","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib38","first-page":"S267","article-title":"Kinetics of bone protection by recombinant osteoprotogerin (OPG) therapy in Lewis rats with mycobacteria-induced adjuvant arthritis","volume":"44","author":"Koch","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib39","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1126\/science.286.5445.1732","article-title":"Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme","volume":"286","author":"Matsumoto","year":"1999","journal-title":"Science"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib40","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0092-8674(00)81989-3","article-title":"Organ-specific disease provoked by systemic autoimmunity","volume":"87","author":"Kouskoff","year":"1996","journal-title":"Cell"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib41","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S1074-7613(00)80045-X","article-title":"From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins","volume":"10","author":"Korganow","year":"1999","journal-title":"Immunity"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib42","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/ni772","article-title":"How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease","volume":"3","author":"Matsumoto","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib43","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0248-8663(99)83060-4","article-title":"Animal models and autoimmune diseases","volume":"20","author":"Korganow","year":"1999","journal-title":"Rev Med Intern"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib44","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0002-9440(10)63016-7","article-title":"TRANCE\/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis","volume":"159","author":"Pettit","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib45","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1002\/j.1460-2075.1991.tb04978.x","article-title":"Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis","volume":"10","author":"Keffer","year":"1991","journal-title":"EMBO J"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib46","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/art.10097","article-title":"Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin","volume":"46","author":"Redlich","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib47","first-page":"S47","article-title":"Fc-Osteoprotegerin fusion protein (Fc-OPG) reduces osteoclast numbers and prevents bone destruction in rats with collagen-induced arthritis","volume":"44","author":"Romas","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib48","first-page":"S270","article-title":"Fc-osteoprotegerin (Fc-OPG) fusion protein reduces osteoclast numbers and prevents bone destruction in rats with collagen-induced arthritis","volume":"16","author":"Romas","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib49","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1002\/1529-0131(200112)44:12<2768::AID-ART464>3.0.CO;2-I","article-title":"The osteoprotegerin\/receptor activator of nuclear factor kappaB\/receptor activator of nuclear factor kappaB ligand system in cartilage","volume":"44","author":"Komuro","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.61.suppl_2.ii84_bib50","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/art.10114","article-title":"Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium","volume":"46","author":"Hou","year":"2002","journal-title":"Arthritis Rheum"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724434778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724434778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.61.suppl_2.ii84","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T05:37:37Z","timestamp":1736141857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724434778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11]]},"references-count":50,"alternative-id":["S0003496724434778"],"URL":"https:\/\/doi.org\/10.1136\/ard.61.suppl_2.ii84","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2002,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone destruction in arthritis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.61.suppl_2.ii84","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 Copyright 2002 by Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}